Related references
Note: Only part of the references are listed.Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review
Nicolas Kerckhove et al.
FRONTIERS IN PHARMACOLOGY (2017)
Chemotherapy-Induced Peripheral Neuropathy: A Current Review
Nathan P. Staff et al.
ANNALS OF NEUROLOGY (2017)
Chemotherapy in primary osteogenic sarcoma in patients over the age of forty
Bulent Ozkurt et al.
ACTA ORTHOPAEDICA ET TRAUMATOLOGICA TURCICA (2017)
Zoledronate in combination with chemotherapy and surgery to treat osteosarcoma (OS2006): a randomised, multicentre, open-label, phase 3 trial
Sophie Piperno-Neumann et al.
LANCET ONCOLOGY (2016)
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial
Neyssa M. Marina et al.
LANCET ONCOLOGY (2016)
Effect of age on drug metabolism in women with breast cancer
Jasmeet C. Singh et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial
Stefan S. Bielack et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prognostic Factors in Elderly Osteosarcoma Patients: A Multi-institutional Retrospective Study of 86 Cases
Shintaro Iwata et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
J. S. Whelan et al.
ANNALS OF ONCOLOGY (2012)
Neoadjuvant Chemotherapy With Methotrexate, Cisplatin, and Doxorubicin With or Without Ifosfamide in Nonmetastatic Osteosarcoma of the Extremity: An Italian Sarcoma Group Trial ISG/OS-1
Stefano Ferrari et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Osteosarcoma of the pelvis: a monoinstitutional experience in patients younger than 41 years
Stefano Ferrari et al.
TUMORI JOURNAL (2012)
Dose adjustment and supportive care before and during treatment
Antonella Brunello et al.
CANCER TREATMENT REVIEWS (2009)
Primary metastatic osteosarcoma:: Presentation and outcome of patients treated on neoadjuvant cooperative osteosarcoma study group protocols
L Kager et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric oncology group study POG-8651
AM Goorin et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Osteosarcoma of the pelvis:: Experience of the Cooperative Osteosarcoma Study Group
T Ozaki et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Osteosarcoma over the age of forty
RJ Grimer et al.
EUROPEAN JOURNAL OF CANCER (2003)
Share Paper
